Abstract
This study introduces an easy method of preparing xyloglucan hydrogel from xyloglucan, which is purified from tamarind seed gum. Xyloglucan hydrogel was prepared in 2 wt% solution by treating with β-galactosidase. Physical and chemical properties (molecular mass, size and viscosity) of xyloglucan hydrogel and xyloglucan solution were tested for a comparison. Experiments of drug release in vitro and in vivo were operated to investigate the potentialities of xyloglucan hydrogel as the biomedical sustained-release carriers for drug delivery system.
Similar content being viewed by others
References
Mishra A, Malhotra AV. Tamarind xyloglucan: a polysaccharide with versatile application potential. J Mater Chem. 2009;19:8528–36.
Nishinari K, Takemasa M, Yamatoya K, Shirakawa M. Xyloglucan. In: Phillips GO, Williams PA, editors. Handbook of hydrocolloids. Cambridge: Woodhead Publishing; 2009. p. 535–66.
Lucyszyn N, Lubambo AF, Ono L, Jó TA, De Souza KF, Sierakowski MR. Chemical, physico-chemical and cytotoxicity characterisation of xyloglucan from Guibourtia hymenifolia (Moric.) J. Leonard seeds. Food Hydrocoll. 2011;25:1242–50.
Cao Y, Gu Y, Ma H, Bai J, Liu L, Zhao P, He H. Self-assembled nano drug delivery systems from galactosylated polysaccharide–doxorubicin conjugate loaded doxorubicin. Int J Biol Macromol. 2010;46:245–9.
Cao Y, Chen D, Zhao P, Liu L, Huang X, Qi C, Liu Y, He H, Wang Q, Liu Y, Chen S. Intracellular delivery of mitomycin C with targeted polysaccharide conjugates against multidrug resistance. Ann Biomed Eng. 2011;39(9):2456–65.
Cao Y, Ikeda I. Antioxidant activity and antitumor activity (in vitro) of xyloglucan selenious ester and surfated xyloglucan. Int J Biol Macromol. 2009;45:231–5.
Coviello T, Matricardi P, Alhaique F. Drug delivery strategies using polysaccharidic gels. Drug Deliv. 2006;3:395–404.
Sandolo C, Matricardi P, Alhaique F, Coviello T. Characterization of polysaccharide hydrogels for modified drug delivery. Food Hydrocoll. 2009;23:210–20.
Yoo MK, Choi HK, Kim TH. Drug release from xyloglucan beads coated with Eudragit for oral drug delivery. Arch Pharmacal Res. 2005;28:736–42.
Rinaudo M. Advances in characterization of polysaccharides in aqueous solution and gel state. In: Dumitriu S, Dekker M, editors. Polysaccharides structural diversity and functional versatility. NY: Marcel Dekker; 2004. p. 237–53.
Shirakawa M, Yamatoya K, Nishinari K. Tailoring of xyloglucan properties using an enzyme. Food Hydrocoll. 1998;12:25–8.
Kawasaki N, Ohkura R, Miyazaki S, Uno Y, Sugimoto Y, Attwood D. Thermally reversible xyloglucan gels as vehicles for oral drug delivery. Int J Pharm. 1999;181:227–34.
Amanda K, Brun-Graeppi AS, Richard C, Bessodes M, Scherman D, Narita T, Ducouret G, Merten O-W. Study on the sol–gel transition of xyloglucan hydrogels. Carbohydr Polym. 2010;80:556–63.
Yang Z, Yang L. Research status and prospective development of hydrogel. Chem Intermed (Chinese). 2007;1:5–10.
Liu W, Yao K, Qi W. Advances in hydrogel. Polym Mater Sci Eng (Chinese). 2002;18:54–57.
Seo SJ, Park IK, Yoo MK. Xyloglucan as a synthetic extracellular matrix for hepatocyte attachment. J biomater Sci Polym Ed. 2004;15:1375–87.
Coviello T, Matricardi P, Marianecci C, Alhaique F. Polysaccharide hydrogels for modified release formulations. J Controlled Release. 2007;119:5–24.
Miyazaki S, Yokouchi C, Nakamura T, Hashiguchi N, Hou WM, Takada M. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin. Chem Pharm Bull. 1986;34:1801–8.
Kang F, Singh J. In vitro release of insulin and biocompatibility of in situ forming gel systems. Int J Pharm. 2005;304:83–90.
Miyazaki S, Tobiyama T, Takada M, Attwood D. Percutaneous absorption of indomethacin from Pluronic F127 gels in rats. J Pharm Pharmacol. 1995;47:455–7.
Miyazaki S, Ohkawa Y, Takada M, Attwood D. Antitumor activity of Pluronic F127 gel containing mitomycin C on sarcoma-180 ascites tumor in mice. Chem Pharm Bull. 1992;40:2224–6.
He M, Zhang H, Chen X, Dong X. Polymer physics (Chinese). 3rd ed. Fudan University Press; 2007.
Itoh K, Tsuruya R, Shimoyama T, Watanabe H, Miyazaki S, D’Emanuele A, Attwood D. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients. Drug Dev Ind Pharm. 2009;36:355–449.
Miyazaki S, Endo K, Kawasaki N, Kubo W, Watanabe H, Attwood D. Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations. Drug Dev Ind Pharm. 2003;29:113–9.
Acknowledgments
This work was supported by the Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry, 2010–1174), self-determined research funds of CCNU from the colleges’ basic research and operation of MOE (CCNU11A02013) and the project of Hubei Key Laboratory of Genetic Regulation and Integrative Biology (201002).
Author information
Authors and Affiliations
Corresponding author
Additional information
Didi Chen and Pei Guo contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chen, D., Guo, P., Chen, S. et al. Properties of xyloglucan hydrogel as the biomedical sustained-release carriers. J Mater Sci: Mater Med 23, 955–962 (2012). https://doi.org/10.1007/s10856-012-4564-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-012-4564-z